Tyvaso and Urinary tract disorder - a phase IV clinical study of FDA data
Summary:
Urinary tract disorder is reported as a side effect among people who take Tyvaso (treprostinil sodium), especially for people who are male, 60+ old, also take Letairis, and have Primary pulmonary hypertension.
The phase IV clinical study analyzes which people have Urinary tract disorder when taking Tyvaso. It is created by eHealthMe based on reports of 37,923 people who have side effects when taking Tyvaso from the FDA, and is updated regularly.
What is Tyvaso?
Tyvaso has active ingredients of treprostinil sodium. eHealthMe is studying from 37,941 Tyvaso users. Check the latest studies of Tyvaso.
What is Urinary tract disorder?
Urinary tract disorder is found to be associated with 542 drugs and 555 conditions by eHealthMe. Check the latest studies of Urinary tract disorder.
37,923 people reported to have side effects when taking Tyvaso.
Among them, 12 people (0.03%) have Urinary tract disorder.

Among these 12 people:
What is the gender of people who have Urinary tract disorder when taking Tyvaso? *
- female: 16.67 %
- male: 83.33 %
What is the age of people who have Urinary tract disorder when taking Tyvaso? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 16.67 %
- 60+: 83.33 %
What are other drugs people take besides Tyvaso? *
- Letairis: 7 people, 58.33%
- Prolia: 5 people, 41.67%
- Durezol: 5 people, 41.67%
- Imodium A-D: 5 people, 41.67%
- Zofran: 5 people, 41.67%
- Aspirin: 5 people, 41.67%
- Amoxicillin: 5 people, 41.67%
- Ambrisentan: 5 people, 41.67%
- Tylenol: 5 people, 41.67%
- Vitamin D3: 5 people, 41.67%
What are other side effects people have besides Urinary tract disorder? *
- Cough: 7 people, 58.33%
- Seasonal Allergy (allergic condition due to certain season): 7 people, 58.33%
- Skin Blushing/flushing (a sudden reddening of the face, neck): 6 people, 50.00%
- Nausea (feeling of having an urge to vomit): 6 people, 50.00%
- Weight Increased: 5 people, 41.67%
- Fatigue (feeling of tiredness): 5 people, 41.67%
- Liver Function Test Abnormal: 5 people, 41.67%
- Kidney Stones: 5 people, 41.67%
- Hypoacusis (loss of hearing): 5 people, 41.67%
- Food Allergy: 5 people, 41.67%
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 8 people, 66.67%
- High Blood Pressure: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Tyvaso and have Urinary tract disorder?
- Check whether Urinary tract disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Tyvaso:
- Tyvaso (37,941 reports)
Urinary tract disorder treatments and more:
- Urinary tract disorder (7,703 reports)
How severe was Urinary tract disorder and when was it recovered:
Expand to all the drugs that have ingredients of treprostinil sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tyvaso:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Urinary tract disorder:
- Urinary tract disorder (542 drugs)
Browse all the conditions that are associated with Urinary tract disorder:
- Urinary tract disorder (555 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on treprostinil sodium (the active ingredients of Tyvaso) and Tyvaso (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Exjade cause Enlarged Prostate? - 8 seconds ago
- Bone Pain and Hypoventilation - 10 seconds ago
- Birth Control and Anxiety Aggravated - 10 seconds ago
- Could Ocrevus cause Blood Glucose Fluctuation? - 12 seconds ago
- Could Lantus cause Corneal Disorder? - 19 seconds ago
- Could Ocrevus cause Device Dislocation? - 19 seconds ago
- Could Ultram Er cause Acute Kidney Failure? - 21 seconds ago
- Could Alprazolam cause Blindness Cortical? - 26 seconds ago
- Could Lyrica cause Suffocation Feeling? - 27 seconds ago
- Drug interactions of Clopidogrel Bisulfate and Donepezil - 29 seconds ago